Join

Compare · ISR vs LH

ISR vs LH

Side-by-side comparison of IsoRay Inc. (ISR) and Labcorp Holdings Inc. (LH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ISR and LH operate in Medical Specialities (Health Care), so they compete in similar markets.
  • LH is the larger of the two at $25.85B, about 505.9x ISR ($51.1M).
  • LH has hit the wire 7 times in the past 4 weeks while ISR has been quiet.
  • LH has more recent analyst coverage (25 ratings vs 1 for ISR).
MetricISRLH
Company
IsoRay Inc.
Labcorp Holdings Inc.
Price
$0.38-1.03%
$263.82-0.44%
Market cap
$51.1M
$25.85B
1M return
-
-0.86%
1Y return
-
+14.64%
Industry
Medical Specialities
Medical Specialities
Exchange
AMEX
NYSE
IPO
News (4w)
0
7
Recent ratings
1
25
ISR

IsoRay Inc.

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.

LH

Labcorp Holdings Inc.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Latest ISR

Latest LH